Role of glutamate in neurodegeneration of dopamine neurons in several animal models of parkinsonism

Amino Acids

Volumn 14, Issue 1-3, 1998, Pages 69-74

  Sonsalla, P K ^a   Albers, D S ^a   Zeevalk, G D ^a  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Basal ganglia; Dopamine; Glutamate; Malonate; Mesencephalic cultures; Methamphetamine; Mice; MK 801; MPTP; NMDA receptors

Indexed keywords

4 PHOSPHONOMETHYLPIPECOLIC ACID; DIZOCILPINE; GLUTAMIC ACID; MALONIC ACID; METHAMPHETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; HYPERTHERMIA; MESENCEPHALON; METABOLIC INHIBITION; NERVE DEGENERATION; NEUROTOXICITY; NONHUMAN; PARKINSONISM; PRIORITY JOURNAL; SUBSTANTIA NIGRA;

ANIMALS; DISEASE MODELS, ANIMAL; DOPAMINE; GLUTAMIC ACID; MICE; NEURONS; PARKINSON DISEASE; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 0031985359     PISSN: 09394451     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01345245     Document Type: Conference Paper

References (13)

1. Albers DA, Sonsalia PK (1995) Methamphetamine-induced hyperthermia and dopaminergic neurotoxicity in mice: pharmacological profile of protective and nonprotective agents. J Pharmacol Exp Ther 275: 1104-1114
2. Bowyer JF, Davies DL, Schmued L, Broening HW, Newport GD, Sliker, W Jr, Holson RR (1994) Further studies of the role of hyperthermia in methamphetamine neurotoxicity. J Pharmacol Exp Ther 268: 1571-1580
3. Chan P, Di Monte DA, Luo J-J, DeLanney LE, Irwin I, Langston JW (1994) Rapid ATP loss caused by methamphetamine in the mouse striatum: relationship between energy impairment and dopaminergic neurotoxicity. J Neurochem 62: 2484-2487
4. Chan P, Di Monte DA, Langston JW, Janson AM (1997) (+)MK-801 does not prevent MPTP-induced loss of nigral neurons in mice. J Pharmacol Exp Ther 280: 439-446
5. Pang Z, Geddes JW (1997) Mechanisms of cell death induced by the mitochondrial toxin 3-nitroproionic acid: acute excitotoxic necrosis and delayed apoptosis. J Neurosci 17: 3064-3073
6. Novelli A, Reilly JA, Lysko PG, Henneberry RC (1988) Glutamate becomes neurotoxic via the NMDA receptor when intracellular energy levels are reduced. Brain Res 451: 205-212
7. Sonsalla PK, Nicklas WJ (1992) MPTP and animal models of Parkinson's disease. In: Koller WC (ed) Handbook of Parkinson's disease, 2nd edn. Marcel Dekker, New York, pp 319-340
8. Sonsalla PK, Nicklas WJ, Heikkila RE (1989) Role for excitatory amino acids in methamphetamine-induced nitrostriatal dopaminergic neurotoxicity. Science 243: 398-400
9. Sonsalla PK, Riordan DE, Heikkila RE (1991) Competetive and noncompetitive antagonists at N-methyl-D-aspartate receptors protect against methamphetamine-induced dopaminergic damage in mice. J Pharmacol Exp Ther 256: 506-512
10. Zeevalk GD, Nicklas WJ (1991) Mechanisms underlying initiation of excitototxicity associated with metabolic inhibition. J Pharmacol Exp Ther 257: 870-878
11. Zeevalk GD, Derr-Yellin E, Nicklas WJ (1995a) NMDA receptor involvement in toxicity to dopamine neurons in vitro caused by the succinate dehydrogenase inhibitor 3-nitroproprionic acid. J Neurochem 64: 455-458
12. Zeevalk GD, Derr-Yellin E, Nicklas WJ (1995b) Relative vulnerability of dopamine and GABA neurons in mesencephalic culture to inhibition of succinate dehydrogenase by malonate and 3-nitroproprionic acid and protection by NMDA receptor blockade. J Pharmacol Exp Ther 275: 1124-1130
13. Zeevalk GD, Manzino L, Hoppe J, Sonsalla PK (1997) In vivo vulnerability of dopamine neurons to inhibition of energy metabolism. Eur J Pharmacol 320: 111-119